2.22
7.25%
0.15
Dopo l'orario di chiusura:
2.21
-0.01
-0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GANX Giù?
Forum
Previsione
Gain Therapeutics Inc Azioni (GANX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.1153
|
- | 0.106 | 0.1299 | 0.0552 |
Operating Expenses
|
0.67%
4.3777
|
4.4072 | 4.885 | 7.7311 | 5.285 |
Benefits Costs and Expenses |
12.74%
4.1096
|
4.7095 | 4.8028 | 7.7913 | 5.1758 |
Costs And Expenses |
12.74%
4.1096
|
4.7095 | 4.8028 | 7.7913 | 5.1758 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
0.67%
-4.3777
|
-4.4072 | -4.885 | -7.7311 | -5.2298 |
Net Interest Income/Expense |
8.50%
0.1153
|
0.1063 | 0.106 | 0.1299 | 0.152 |
Interest Income/Expense After Provision For Losses |
8.50%
0.1153
|
0.1063 | 0.106 | 0.1299 | 0.152 |
Income/Loss From Continuing Operations Before Tax |
15.19%
-3.9943
|
-4.7095 | -4.6968 | -7.6614 | -5.1206 |
Income Tax Expense/Benefit |
37.04%
0.0199
|
0.0145 | 0.0215 | 0.0266 | 0.0167 |
Income/Loss From Continuing Operations After Tax |
15.02%
-4.0142
|
-4.724 | -4.7183 | -7.688 | -5.1373 |
Net Income/Loss
|
15.02%
-4.0142
|
-4.724 | -4.7183 | -7.688 | -5.1373 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,586%
17.98
|
0.6693 | 12.70 | 12.39 | 11.94 |
Diluted Average Shares |
2,586%
17.98
|
0.6693 | 12.70 | 12.39 | 11.94 |
Basic Earnings Per Share |
24.14%
-0.22
|
-0.29 | -0.37 | -0.62 | -0.43 |
Diluted Earnings Per Share |
24.14%
-0.22
|
-0.29 | -0.37 | -0.62 | -0.43 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):